About
Hydroxyl Technologies Ltd was born from the technological development previously achieved by Tri-Air Developments Ltd.
Tri-Air took the novel technology created by inventor Alan Mole, and in partnership with Alan and BRE Ltd undertook over 10 years of technological development, testing, prototyping, focus groups, and extensive microbiological and air quality testing at numerous laboratories around the world, including the UK Health Protection Agency (HPA) at Porton Down.
The HPA microbiologists recommended that we tested the technology on MS2 phage as a surrogate for all human pathogens because they know that MS2 phage* is much tougher to kill than any pathogenic virus. The results of those tests was very positive, achieving a kill rate of 99.9999% of airbourne MS2 in under 5 minutes.
Tri-Air underwent a change of investors in late 2015, which led to the company being wound up and the IPR and know how transferred to Hydroxyl Technologies Ltd, a new company formed by a group of the original founders led by Lorraine Baldry.
We knew from the beginning that Alan Mole, the brilliant mind behind Airora, had invented something very special. But we also knew that the science was so novel that it would be tough to develop, test and implement the appropriate technology.
As expected, the journey has been really challenging, but after ten years of research and development the technology we have developed is now thoroughly proven and both low cost and straightforward to manufacture.
We are incredibly excited to be able to make our next generation air cleaning solutions available to customers worldwide, and you can find out more about our initial products under the brand name Airora, at https://www.airora.com.
* The HPA (Health Protection Agency) at Porton Down use MS2- phage instead of pathogenic viruses because “under health and safety law (COSHH) substitution of pathogenic agents by non-pathogens is recommended when possible, and MS2 phage is a virus with well documented high resistance to chemical and physical modes of control” (Dr. Allan Bennett, HPA).
Tri-Air took the novel technology created by inventor Alan Mole, and in partnership with Alan and BRE Ltd undertook over 10 years of technological development, testing, prototyping, focus groups, and extensive microbiological and air quality testing at numerous laboratories around the world, including the UK Health Protection Agency (HPA) at Porton Down.
The HPA microbiologists recommended that we tested the technology on MS2 phage as a surrogate for all human pathogens because they know that MS2 phage* is much tougher to kill than any pathogenic virus. The results of those tests was very positive, achieving a kill rate of 99.9999% of airbourne MS2 in under 5 minutes.
Tri-Air underwent a change of investors in late 2015, which led to the company being wound up and the IPR and know how transferred to Hydroxyl Technologies Ltd, a new company formed by a group of the original founders led by Lorraine Baldry.
We knew from the beginning that Alan Mole, the brilliant mind behind Airora, had invented something very special. But we also knew that the science was so novel that it would be tough to develop, test and implement the appropriate technology.
As expected, the journey has been really challenging, but after ten years of research and development the technology we have developed is now thoroughly proven and both low cost and straightforward to manufacture.
We are incredibly excited to be able to make our next generation air cleaning solutions available to customers worldwide, and you can find out more about our initial products under the brand name Airora, at https://www.airora.com.
* The HPA (Health Protection Agency) at Porton Down use MS2- phage instead of pathogenic viruses because “under health and safety law (COSHH) substitution of pathogenic agents by non-pathogens is recommended when possible, and MS2 phage is a virus with well documented high resistance to chemical and physical modes of control” (Dr. Allan Bennett, HPA).
